{"id":556978,"date":"2026-06-22T22:10:47","date_gmt":"2026-06-22T20:10:47","guid":{"rendered":"https:\/\/medizinonline.com\/induction-et-maintien-de-la-remission-avec-des-medicaments-biologiques-et-jak-i\/"},"modified":"2026-05-18T13:19:55","modified_gmt":"2026-05-18T11:19:55","slug":"induction-et-maintien-de-la-remission-avec-des-medicaments-biologiques-et-jak-i","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/induction-et-maintien-de-la-remission-avec-des-medicaments-biologiques-et-jak-i\/","title":{"rendered":"Induction et maintien de la r\u00e9mission avec des m\u00e9dicaments biologiques et JAK-i"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;objectif principal du traitement de la colite ulc\u00e9reuse est la r\u00e9mission clinique et endoscopique. En cas d&#8217;activit\u00e9 mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re de la maladie, plusieurs options d&#8217;escalade th\u00e9rapeutique sont disponibles. Une \u00e9tude non interventionnelle a mis en lumi\u00e8re l&#8217;option de l&#8217;utilisation du vedolizumab et du tofacitinib apr\u00e8s un \u00e9chec du traitement anti-TNF\u03b1 et une analyse secondaire r\u00e9cente a examin\u00e9 l&#8217;utilisation des inhibiteurs de l&#8217;IL-23p19.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Finduction-et-maintien-de-la-remission-avec-des-medicaments-biologiques-et-jak-i%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;objectif principal du traitement de la colite ulc\u00e9reuse est la r\u00e9mission clinique et endoscopique. En cas d&#8217;activit\u00e9 mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re de la maladie, plusieurs options d&#8217;escalade th\u00e9rapeutique sont disponibles. Une&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Finduction-et-maintien-de-la-remission-avec-des-medicaments-biologiques-et-jak-i%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":556980,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Colite ulc\u00e9reuse : donn\u00e9es probantes actuelles sur les traitements anti-inflammatoires  ","footnotes":""},"category":[11549,11527,11414,11315,11535],"tags":[93872,93872,16021,15761,21625,93875,59318,93877,93878,65783,65783,93876,93873,15758,12408,93874,21282,21292],"powerkit_post_featured":[],"class_list":["post-556978","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-etudes","category-gastro-enterologie-et-hepatologie","category-medecine-interne-generale","category-rapports-de-congres","tag-anti-tnf","tag-ced-fr","tag-colite-ulcereuse","tag-echec-du-traitement","tag-escalade-therapeutique-2","tag-escalade-therapeutique","tag-induction-de-la-remission","tag-inhibiteurs-de-lil-23p19","tag-jak-i-fr","tag-les-therapies-anti-inflammatoires","tag-maintien-de-la-remission","tag-maladie-de-crohn","tag-medicaments-biologiques","tag-remission-clinique-et-endoscopique","tag-tofacitinib-fr","tag-vedolizumab-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-05 13:54:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":556974,"slug":"induzione-e-mantenimento-della-remissione-con-biologici-e-jak-i","post_title":"Induzione e mantenimento della remissione con biologici e JAK-i","href":"https:\/\/medizinonline.com\/it\/induzione-e-mantenimento-della-remissione-con-biologici-e-jak-i\/"},"pt_PT":{"locale":"pt_PT","id":556970,"slug":"inducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i","post_title":"Indu\u00e7\u00e3o e manuten\u00e7\u00e3o da remiss\u00e3o com produtos biol\u00f3gicos e JAK-i","href":"https:\/\/medizinonline.com\/pt-pt\/inducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i\/"},"es_ES":{"locale":"es_ES","id":556966,"slug":"induccion-y-mantenimiento-de-la-remision-con-biologicos-y-jak-i","post_title":"Inducci\u00f3n y mantenimiento de la remisi\u00f3n con biol\u00f3gicos y JAK-i","href":"https:\/\/medizinonline.com\/es\/induccion-y-mantenimiento-de-la-remision-con-biologicos-y-jak-i\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=556978"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556978\/revisions"}],"predecessor-version":[{"id":556981,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556978\/revisions\/556981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/556980"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=556978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=556978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=556978"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=556978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}